logo

DXCM

Dexcom·NASDAQ
--
--(--)
--
--(--)

DXCM fundamentals

Dexcom (DXCM) expects to report earnings on Feb 12, 2026, with estimated revenue of 1.25B (YoY +12.10%), and EPS at 0.6498 (YoY +44.40%).
Revenue estimate / YoY
1.25B
+12.10%
EPS estimate / YoY
0.6498
+44.40%
Report date
Feb 12, 2026
Earnings Call
4:30 PM on Feb 12, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

DXCM has released its 2025 Q3 earnings report, with revenue of 1.21B, reflecting a YoY change of 21.64%, and net profit of 283.80M, showing a YoY change of 110.85%. The Sankey diagram below clearly presents DXCM's revenue sources and cost distribution.

Key Indicators

Dexcom (DXCM) key financial stats and ratios, covering profitability, financial health, and leverage.
Dexcom (DXCM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Dexcom (DXCM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Dexcom (DXCM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Dexcom (DXCM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Dexcom (DXCM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield